World Library  
Flag as Inappropriate
Email this Article

Human Microbiome Project

Article Id: WHEBN0016359310
Reproduction Date:

Title: Human Microbiome Project  
Author: World Heritage Encyclopedia
Language: English
Subject: Gut flora, Integrated Microbial Genomes System, Sequence Read Archive, Environmental microbiology, Microbial population biology
Publisher: World Heritage Encyclopedia

Human Microbiome Project

Logo of the Human Microbiome Project.

The Human Microbiome Project (HMP) was a United States human microbiome). Launched in 2008,[1] it was a five-year project, best characterized as a feasibility study, and had a total budget of $115 million. The ultimate goal of this and similar NIH-sponsored microbiome projects was to test how changes in the human microbiome are associated with human health or disease. This topic is currently not well understood.

Important components of the Human Microbiome Project were culture-independent methods of microbial community characterization, such as metagenomics (which provides a broad genetic perspective on a single microbial community), as well as extensive whole genome sequencing (which provides a "deep" genetic perspective on certain aspects of a given microbial community, i.e. of individual bacterial species). The latter served as reference genomic sequences — 3000 such sequences of individual bacterial isolates are currently planned — for comparison purposes during subsequent metagenomic analysis. The microbiology of five body sites was emphasized: oral, skin, vaginal, gut, and nasal/lung. The project also financed deep sequencing of bacterial 16S rRNA sequences amplified by polymerase chain reaction from human subjects.[2]


Depiction of prevalences of various classes of bacteria at selected sites on human skin.

Total microbial bacteriophages, the viruses of bacteria).

The HMP will address some of the most inspiring, vexing and fundamental scientific questions today. Importantly, it also has the potential to break down the artificial barriers between medical microbiology and environmental microbiology. It is hoped that the HMP will not only identify new ways to determine health and predisposition to diseases but also define the parameters needed to design, implement and monitor strategies for intentionally manipulating the human microbiota, to optimize its performance in the context of an individual's physiology.[3]

The HMP has been described as "a logical conceptual and experimental extension of the [5] The Canadian Institutes of Health Research, through the CIHR Institute of Infection and Immunity, is leading the Canadian Microbiome Initiative[6] to develop a coordinated and focused research effort to analyze and characterize the microbes that colonize the human body and their potential alteration during chronic disease states.


The HMP includes the following goals:[7]

  • To develop a reference set of microbial genome sequences and to perform preliminary characterization of the human microbiome
  • To explore the relationship between disease and changes in the human microbiome
  • To develop new technologies and tools for computational analysis
  • To establish a resource repository
  • To study the ethical, legal, and social implications of human microbiome research


The impact to date of the Human Microbiome Project may be partially assessed by examination of research sponsored by the HMP. Over 190 peer-reviewed publications are listed on the HMP website from June 2009 through August 2012.[8]

Major categories of work funded by HMP include:

  • Development of new database systems allowing efficient organization, storage, access, search and annotation of massive amounts of data. These include IMG, the Integrated Microbial Genomes database and comparative analysis system;[9] IMG/M, a related system that integrates metagenome data sets with isolate microbial genomes from the IMG system;[10] CharProtDB, a database of experimentally characterized protein annotations;[11] and the Genomes OnLine Database (GOLD), for monitoring the status of genomic and metagenomic projects worldwide and their associated metadata.[12]
  • Development of tools for comparative analysis that facilitate the recognition of common patterns, major themes and trends in complex data sets. These include RAPSearch2, a fast and memory-efficient protein similarity search tool for next-generation sequencing data;[13] Boulder ALignment Editor (ALE), a web-based RNA alignment tool;[14] WebMGA, a customizable web server for fast metagenomic sequence analysis;[15] and DNACLUST, a tool for accurate and efficient clustering of phylogenetic marker genes[16]
  • Development of new methods and systems for assembly of massive sequence data sets. No single assembly algorithm addresses all the known problems of assembling short-length sequences,[17] so next-generation assembly programs such as AMOS[18] are modular, offering a wide range of tools for assembly. Novel algorithms have been developed for improving the quality and utility of draft genome sequences.[19]
  • Assembly of a catalog of sequenced reference genomes of pure bacterial strains from multiple body sites, against which metagenomic results can be compared. The original goal of 600 genomes has been far surpassed; the current goal is for 3000 genomes to be in this reference catalog, sequenced to at least a high-quality draft stage. As of March 2012, 742 genomes have been cataloged.[20]
  • Establishment of the Data Analysis and Coordination Center (DACC),[21] which serves as the central repository for all HMP data.
  • Various studies exploring legal and ethical issues associated with whole genome sequencing research.[22][23][24][25]

Developments funded by HMP include:

  • New predictive methods for identifying active transcription factor binding sites.[26]
  • Identification, on the basis of bioinformatic evidence, of a widely distributed, ribosomally produced electron carrier precursor[27]
  • Time-lapse "moving pictures" of the human microbiome.[28]
  • Identification of unique adaptations adopted by segmented filamentous bacteria (SFB) in their role as gut commensals.[29] SFB are medically important because they stimulate T helper 17 cells, thought to play a key role in autoimmune disease.
  • Identification of factors distinguishing the microbiota of healthy and diseased gut.[30]
  • Identification of a hitherto unrecognized dominant role of Verrucomicrobia in soil bacterial communities.[31]
  • Identification of factors determining the virulence potential of Gardnerella vaginalis strains in vaginosis.[32]
  • Identification of a link between oral microbiota and atherosclerosis.[33]
  • Demonstration that pathogenic species of Neisseria involved in meningitis, septicemia, and sexually transmitted disease exchange virulence factors with commensal species.[34]


Reference database established

On 13 June 2012, a major milestone of the Human Microbiome Project (HMP) was announced by the NIH director Francis Collins.[35] The announcement was accompanied with a series of coordinated articles published in Nature [36][37] and several journals in the Public Library of Science (PLoS) on the same day. By mapping the normal microbial make-up of healthy humans using genome sequencing techniques, the researchers of the HMP have created a reference database and the boundaries of normal microbial variation in humans. [38]

From 242 healthy U.S. volunteers, more than 5,000 samples were collected from tissues from 15 (men) to 18 (women) body sites such as mouth, nose, skin, lower intestine (stool) and vagina. All the DNA, human and microbial, were analyzed with DNA sequencing machines. The microbial genome data were extracted by identifying the bacterial specific ribosomal RNA, 16S rRNA. The researchers calculated that more than 10,000 microbial species occupy the human ecosystem and they have identified 81 – 99% of the genera. In addition to establishing the human microbiome reference database, the HMP project also discovered several "surprises", which include:

  • Microbes contribute more genes responsible for human survival than humans' own genes. It is estimated that bacterial protein-coding genes are 360 times more abundant than human genes.
  • Microbial metabolic activities; for example, digestion of fats; are not always provided by the same bacterial species. The presence of the activities seems to matter more.
  • Components of the human microbiome change over time, affected by a patient disease state and medication. However, the microbiome eventually returns to a state of equilibrium, even though the composition of bacterial types has changed.

Clinical application

Among the first clinical applications utilizing the HMP data, as reported in several PLoS papers, the researchers found a shift to less species diversity in vaginal microbiome of pregnant women in preparation for birth, and high viral DNA load in the nasal microbiome of children with unexplained fevers. Other studies using the HMP data and techniques include role of microbiome in various diseases in the digestive tract, skin, reproductive organs and childhood disorders.[35]

Pharmaceutical application


See also


  1. ^
  2. ^
  3. ^ a b
  4. ^
  5. ^
  6. ^
  7. ^
  8. ^
  9. ^
  10. ^
  11. ^
  12. ^
  13. ^
  14. ^
  15. ^
  16. ^
  17. ^
  18. ^
  19. ^
  20. ^
  21. ^
  22. ^
  23. ^
  24. ^
  25. ^
  26. ^
  27. ^
  28. ^
  29. ^
  30. ^
  31. ^
  32. ^
  33. ^
  34. ^
  35. ^ a b
  36. ^
  37. ^
  38. ^ Manuscript Summaries
  39. ^

External links

  • Human Microbiome Project
  • Data Analysis and Coordination Center
  • The CIHR Canadian Microbiome Initiative
  • The International Human Microbiome Consortium
  • 2006, Lay summary of colon microbiome study (the actual study: Gill et al., 2006)
  • Olivia Judson Microbes ‘R’ Us New York Times 22 July 2009
  • Gina Kolata Good Health? Thank Your 100 Trillion Bacteria New York Times 13 June 2012
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.